OPTI — Crescent NV Income Statement
0.000.00%
- €12.36m
- €12.96m
- €11.41m
Annual income statement for Crescent NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18.2 | 17.8 | 16.2 | 21.1 | 11.4 |
Cost of Revenue | |||||
Gross Profit | 5.19 | 5.37 | 5.51 | 7.41 | 3.38 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 22.4 | 22 | 21.1 | 23 | 18.5 |
Operating Profit | -4.17 | -4.22 | -4.83 | -1.92 | -7.09 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.5 | -4.6 | -5.53 | -2.51 | -7.79 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.95 | -4.73 | -5.57 | -2.1 | -7.82 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -4.85 | -4.78 | -5.63 | -2.09 | -7.01 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.85 | -4.78 | -5.63 | -2.09 | -7.01 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.003 | -0.002 | -0.002 | 0 | -0.003 |